Otsuka's Taiho Starts US Filing for Zipalertinib as a First-Line Lung Cancer Combination
1 report from 1 outlet in 1 language · first reported · updated · JSON

Reports
- Otsuka's Taiho Starts US Filing for Zipalertinib as a First-Line Lung Cancer Combinationtokyobrief.com · ja ·